Formyl peptide receptors are involved in CTX-induced impairment of lymphocyte functions.


Journal

Toxicon : official journal of the International Society on Toxinology
ISSN: 1879-3150
Titre abrégé: Toxicon
Pays: England
ID NLM: 1307333

Informations de publication

Date de publication:
15 Jan 2023
Historique:
received: 28 09 2022
revised: 18 11 2022
accepted: 23 11 2022
pubmed: 29 11 2022
medline: 10 1 2023
entrez: 28 11 2022
Statut: ppublish

Résumé

Crotoxin (CTX) is a neurotoxin that is isolated from the venom of Crotalus durissus terrificus, which displays immunomodulatory, anti-inflammatory, and anti-tumoral effects. Previous research has demonstrated that CTX promotes the adherence of leukocytes to the endothelial cells in blood microcirculation and the high endothelial venules of lymph nodes, which reduces the number of blood cells and lymphocytes. Studies have also shown that these effects are mediated by lipoxygenase-derived mediators. However, the exact lipoxygenase-derived eicosanoid involved in the CTX effect on lymphocytes is yet to be characterized. As CTX stimulates lipoxin-derived mediators from macrophages and lymphocyte effector functions could be modulated by activating formyl peptide receptors, we aimed to investigate whether these receptors were involved in CTX-induced redistribution and functions of lymphocytes in rats. We used male Wistar rats treated with CTX to demonstrate that Boc2 (butoxycarbonyl-Phe-Leu-Phe-Leu-Phe), an antagonist of formyl peptide receptors, prevented CTX-induced decrease in the number of circulating lymphocytes and increased the expression of the lymphocyte adhesion molecule LFA1. CTX reduced the T and B lymphocyte functions, such as lymphocyte proliferation in response to the mitogen Concanavalin A and antibody production in response to BSA immunization, respectively, which was prevented by the administration of Boc2. Importantly, mesenteric lymph node lymphocytes from CTX-treated rats showed an increased release of 15-epi-LXA

Identifiants

pubmed: 36442690
pii: S0041-0101(22)00337-3
doi: 10.1016/j.toxicon.2022.106986
pii:
doi:

Substances chimiques

Crotoxin 9007-40-3
Receptors, Formyl Peptide 0
Lipoxygenases EC 1.13.11.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106986

Informations de copyright

Copyright © 2022 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Vanessa O Zambelli (VO)

Laboratory of Pain and Signaling, Butantan Institute, Av. Vital Brazil, 1500, 05503-900, São Paulo, SP, Brazil. Electronic address: vanessa.zambelli@butantan.gov.br.

Natália Gabriele Hösch (NG)

Laboratory of Pain and Signaling, Butantan Institute, Av. Vital Brazil, 1500, 05503-900, São Paulo, SP, Brazil.

Sarah Farom (S)

Laboratory of Pain and Signaling, Butantan Institute, Av. Vital Brazil, 1500, 05503-900, São Paulo, SP, Brazil; Laboratory of Pathophysiology, Butantan Institute, Av. Vital Brazil, 1500, 05503-900, São Paulo, SP, Brazil.

Bianca C Zychar (BC)

Laboratory of Pathophysiology, Butantan Institute, Av. Vital Brazil, 1500, 05503-900, São Paulo, SP, Brazil.

Diva D Spadacci-Morena (DD)

Laboratory of Pathophysiology, Butantan Institute, Av. Vital Brazil, 1500, 05503-900, São Paulo, SP, Brazil.

Luciana Vieira Carvalho (LV)

Laboratory of Immunochemistry, Butantan Institute, Av. Vital Brasil, 1500, 05503-900, São Paulo, SP, Brazil.

Rui Curi (R)

Immunobiological Production Section, Bioindustrial Center, Av. Vital Brazil, 1500, 05503-900, São Paulo, SP, Brazil; Interdisciplinary Post-graduate Program in Health Sciences, Cruzeiro of Sul University, São Paulo, SP, Brazil.

Lucilia B Lepsch (LB)

Department of Pharmacology, Institute of Biomedical Science, University of São Paulo, São Paulo, 05508-900, Brazil.

Cristoforo Scavone (C)

Department of Pharmacology, Institute of Biomedical Science, University of São Paulo, São Paulo, 05508-900, Brazil.

Osvaldo Augusto Sant'Anna (OA)

Laboratory of Immunochemistry, Butantan Institute, Av. Vital Brasil, 1500, 05503-900, São Paulo, SP, Brazil.

Luís Roberto C Gonçalves (LRC)

Laboratory of Pathophysiology, Butantan Institute, Av. Vital Brazil, 1500, 05503-900, São Paulo, SP, Brazil.

Yara Cury (Y)

Laboratory of Pain and Signaling, Butantan Institute, Av. Vital Brazil, 1500, 05503-900, São Paulo, SP, Brazil.

Sandra C Sampaio (SC)

Laboratory of Pathophysiology, Butantan Institute, Av. Vital Brazil, 1500, 05503-900, São Paulo, SP, Brazil. Electronic address: sandra.coccuzzo@butantan.gov.br.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH